122 related articles for article (PubMed ID: 6986970)
1. Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.
Blumenschein GR; Hortobagyi GN; Richman SP; Gutterman JU; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Hersh EM
Cancer; 1980 Feb; 45(4):742-9. PubMed ID: 6986970
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
[TBL] [Abstract][Full Text] [Related]
3. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
[TBL] [Abstract][Full Text] [Related]
4. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
[TBL] [Abstract][Full Text] [Related]
5. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325
[TBL] [Abstract][Full Text] [Related]
6. Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Yap HY; Buzdar AU; Tashima CK; Burgess MA; Hersh EM
Cancer; 1979 Mar; 43(3):1112-22. PubMed ID: 427716
[TBL] [Abstract][Full Text] [Related]
7. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
[TBL] [Abstract][Full Text] [Related]
8. Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.
Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Valdivieso M; Gutterman JU; Hersh EM; Bodey GP
Cancer; 1979 Aug; 44(2):398-405. PubMed ID: 383255
[TBL] [Abstract][Full Text] [Related]
9. Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy.
Hortobagyi GN; Blumenschein GR; Buzdar AU; Yap HY; Schell FC; Barnes BC; Burgess MA
J Surg Oncol; 1981; 18(2):163-72. PubMed ID: 7300363
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of Bacillus Calmette-Guerin (MER) in advanced breast cancer: a randomized trial by the Piedmont Oncology Association.
Muss HB; Richards F; Cooper MR; White DR; Jackson DV; Stuart JJ; Howard V; Shore A; Rhyne AL; Spurr CL
Cancer; 1981 May; 47(9):2295-301. PubMed ID: 7226124
[TBL] [Abstract][Full Text] [Related]
11. Immunochemotherapy in advanced neuroblastoma.
Necheles TF; Rausen AR; Kung FH; Pochedly C
Cancer; 1978 Apr; 41(4):1282-8. PubMed ID: 638992
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum: a prospective randomized study.
Richards F; Muss HB; Cooper R; White DR; Stuart JJ; Howard V; Barnes P; Rhyne L; Spurr CL
Cancer; 1979 Jan; 43(1):91-6. PubMed ID: 367576
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF
J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.
Buzdar AU; Legha SS; Tashima CK; Yap HY; Hortobagyi GN; Hersh EM; Blumenschein GR; Bodey GP
Cancer Treat Rep; 1979 Jan; 63(1):115-20. PubMed ID: 369682
[TBL] [Abstract][Full Text] [Related]
15. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
[TBL] [Abstract][Full Text] [Related]
16. Chemo immunotherapy of advanced breast cancer with BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Buzdar A; Burgess MA; Richman SP; Tashima CK; Schwarz M; Hersh EM
Recent Results Cancer Res; 1977; (62):143-50. PubMed ID: 601328
[No Abstract] [Full Text] [Related]
17. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.
Krutchik AN; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Gutterman JU; Yap HY; Hersh EM
J Surg Oncol; 1979; 11(4):325-32. PubMed ID: 109703
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of alternating cytoreductive and cycle-active combination chemotherapy for metastatic breast cancer.
Vogel CL; Love NH; East DR; Moore MR; Smalley RV
Cancer Treat Rep; 1979; 63(11-12):2077-9. PubMed ID: 526940
[TBL] [Abstract][Full Text] [Related]
19. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
Buzdar AU; Blumenschein GR; Smith TL; Tashima CK; Hortobagyi GN; Yap HY; Gutterman JU; Hersh EM; Gehan EA
J Surg Oncol; 1979; 12(1):27-40. PubMed ID: 480951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
